Stockholm (HedgeNordic) – Rhenman & Partners Asset Management has appointed Teresa Isele as its new CEO to replace co-founder and current CEO Göran Nordström, who is retiring at the age of 69. Isele currently serves as the CEO of SwedSec and will assume her role as CEO of Rhenman & Partners in March next year.
Most recently, Isele has been serving as the CEO of SwedSec, which provides a licensing system for employees within the Swedish financial services industry. Before SwedSec, she spent about six years at AP1, Första AP-fonden, in various roles including acting CEO, general counsel and head of compliance. She also served as a lawyer at EQT for four years and law firm Vinge for an additional two years.
“We are very happy to welcome Teresa to Rhenman & Partners in the role of CEO.”
“We are very happy to welcome Teresa to Rhenman & Partners in the role of CEO,” announces Hans Wigzell, chairman of the board of Rhenman & Partners Asset Management, in a press release. “Her impressive background and expertise in the areas of both law and finance means she is well suited to lead the development work for Rhenman & Partners Asset Management going forward,” he continues. “I would also like to take this opportunity to thank outgoing CEO Göran Nordström for his invaluable contribution during Rhenman & Partners’ first 14 years,” Wigzell comments on Göran Nordström’s retirement.
“I am proud to be joining the team at Rhenman & Partners. Since the start of their journey in 2008, they have managed to create impressive results within the healthcare sector through their unique way of working, which has been recognized by numerous awards within the fund industry,” comments Teresa Isele, the incoming CEO of the Swedish asset manager running healthcare-focused equity hedge fund Rhenman Healthcare Equity L/S. “Rhenman & Partners is well equipped for the future despite a challenging macro environment. I look forward to continuing the development of the business together with the highly competent employees.”
Rhenman & Partners Asset Management has been running its long-biased equity hedge fund with an exclusive focus on healthcare since mid-2009, delivering an annualized return of 17.3 percent through August 2022. The fund’s main share class (IC1 EUR) edged down 6.2 percent in the first eight months of this year. Rhenman Healthcare Equity L/S oversees €910 million in assets under management.
